NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Medisola

Medisola

Private
SeoulHealthcare & Life Scienceshttps://www.medisola.co.kr/

Last Round

Series A

Apr 3, 2025

Total Funding Raised

$11.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Medisola is a food-tech company that provides personalized nutritional solutions and meal plans based on medical data and AI for preventative health and disease management.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Medical AI, Subscription Commerce

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

personalized nutritionmedically tailored mealsfood as medicinechronic disease managementAI meal planningdigital health platformnutritional analysispreventive nutritionready-to-eat mealsfood-techemployee assistance programsEAPclinical nutritionsubscription meal service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medisola Comps

Public and private peers based on sector, stage, and business model.

Medisola comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Medisola Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 3, 2025

Key People

Founding team and executive leadership

Young-Gil Yoon

경영지원실장(CFO) 상무

Executive Team

Junseung Lee

CPO

Executive Team

Medisola Investors

Notable investors and investment history

Medisola investors
InvestorRounds
Premier PartnersSeries A
Samsung Venture InvestmentSeries A
Redbadge PacificSeries A
Samsung Venture InvestmentSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Monthly visitors grew 105% MoM, reaching 33.7K.

  • Apr 7, 2025

    Developing ArchenX, an AI platform for diet planning and digital meal prescriptions.

Medisola Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Medisola Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medisola's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range8
Year Founded2021
Last FundingApr 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.